Morano F, Raimondi A, Pagani F, Lonardi S, et al. Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. J Clin Oncol 2022 Mar 8:JCO2102583. doi: 10.1200/JCO.21.02583.
PMID: 35258987